Manulife (Manufacturers Life Insurance)
VTGN icon

Manulife (Manufacturers Life Insurance)’s VistaGen Therapeutics VTGN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,516
Closed -$6.92K – 3004
2022
Q3 		$6.92K Sell
1,516
-1,213
-44% -$12K ﹤0.01% 2949
2022
Q2 		$72K Sell
2,729
-9
-0.3% -$318 ﹤0.01% 2977
2022
Q1 		$102K Sell
2,738
-767
-22% -$33.4K ﹤0.01% 2955
2021
Q4 		$205 Buy
3,505
+47
+1% +$3.06K ﹤0.01% 2877
2021
Q3 		$284K Sell
3,458
-224
-6% -$19.5K ﹤0.01% 2719
2021
Q2 		$348K Buy
+3,682
New +$273K ﹤0.01% 2703

Other funds holding VTGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VTGN Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of VistaGen Therapeutics (VTGN) in Q4 2022, closing a stake of 1,516 shares — an estimated $6.92K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VTGN in Q2 2021 and held it in 6 quarters. The position peaked at $348K in Q2 2021. 85 funds tracked by Wall St. Rank hold VTGN as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining VistaGen Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,516 VistaGen Therapeutics shares in Q4 2022, an estimated $6.92K.
  • Manulife (Manufacturers Life Insurance) first reported a position in VistaGen Therapeutics in Q2 2021 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s VistaGen Therapeutics position peaked at $348K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.